
Synergy Shield Coronary Stent 2.25 X 8 | REF H7493966608220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 8 mm, REF H7493966608220. Single-unit B2B catalog listing for hospital and cath lab procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS2512ASM) is a thin-strut, sirolimus-eluting coronary stent system in a 2.50 mm × 12 mm configuration, mounted on a rapid-exchange percutaneous transluminal coronary angioplasty (PTCA) delivery catheter. It belongs to the Ultimaster family of bioresorbable polymer drug-eluting stents engineered by Terumo for routine and complex coronary interventions.
Key Features
- Cobalt-chromium stent platform with thin-strut architecture for low-profile deliverability
- Sirolimus drug coating with bioresorbable PDLLA-PCL polymer applied to the abluminal surface
- Rapid-exchange delivery catheter designed for navigation through tortuous anatomy
- 2.50 mm nominal expanded diameter and 12 mm stent length
- Radiopaque markers to support fluoroscopic placement
- Single-use, sterile, supplied pre-mounted
Clinical Applications
- Percutaneous coronary intervention (PCI) in native coronary arteries
- Treatment of de novo coronary artery lesions in vessels with reference diameter suitable for a 2.50 mm device
- Use in workhorse and selected complex lesion subsets per operator discretion and the manufacturer Instructions for Use
Product Information
- Brand: Terumo
- Product Line: Ultimaster Nagomi
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: DE-RS2512ASM
- Stent Diameter: 2.50 mm
- Stent Length: 12 mm
- Delivery System: Rapid exchange (Monorail)
- Drug: Sirolimus
- Polymer: Bioresorbable (PDLLA-PCL), abluminal coating
- Platform Material: Cobalt-chromium alloy
- Sterility: Sterile, single use
- Guidewire Compatibility: Not specified in the located sources
- Guiding Catheter Compatibility: Not specified in the located sources
- Maximum Expansion Diameter: Not specified in the located sources
- Regulatory Status: Refer to local regulatory documentation and the official Instructions for Use
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.